Tyrer-Cuzick and NCCN: Quick Crash Course for Breast Centers in 2024
How NCCN Guidelines and the Tyrer-Cuzick Lifetime Model differ and why programs are missing patients.
How NCCN Guidelines and the Tyrer-Cuzick Lifetime Model differ and why programs are missing patients.
The changing season is the perfect time for health systems to upgrade their screening programs to support cancer prevention and early detection...
The average breast program provides one-size-fits-all preventive care that fails to meet the needs of the 1 in 10 women, like Jill Martin, with the...
Our latest offerings underscore our commitment to the genetics community, high-risk program outcomes, and continued innovation in precision...
This year we were excited to see growing momentum around personalized prevention & early detection of cancer. Read on for our top 3 three takeaways...
Your curated February 2023 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity,...
Your curated January 2023 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity, &...
One of the greatest sources of untapped revenue lies in oncology, where an unmet need for cancer prevention also promises to drive innovation...
Your curated December 2022 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity,...
CancerIQ data shows 2 in 5 patients who undergo comprehensive cancer risk assessment and genetic testing require a change in medical management.